Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Has announcements
×
Neoplasm, Residual
×
Clear all
Filters
3
NCT01207388
2020-02-10
BLAST
Amgen Research (Munich) GmbH
Phase 2
Completed
116 enrolled
23 charts
1 FDA